AstraZeneca PLC American Depositary Shares (AZN)
NASDAQ (NGS) NASDAQ (NGS) Primary 
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with the GLP-1 drug class.
3 Magnificent Stocks Under $100 to Buy in November
The price could be right for these stocks.
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
In the most recent trading session, Astrazeneca (AZN) closed at $71.42, indicating a +0.38% shift from the previous trading day.
AstraZeneca hit again as Chinese president investigated by police
AstraZeneca PLC (LSE:AZN) has confirmed that the president of its China division has been placed under investigation by local police as part of an anti-corruption drive. Leon Wang, who forms part of its senior executive team, is cooperating with an investigation by Chinese authorities said a statement yesterday from the pharma group released during the Budget speech without giving further details.
AstraZeneca says its China operations president under investigation
AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating with Chinese authorities.
Astrazeneca (AZN) Declines More Than Market: Some Information for Investors
Astrazeneca (AZN) closed the most recent trading day at $75.05, moving -1.12% from the previous trading session.
AstraZeneca positioned for success in key breast cancer drug trials, says leading US investment bank
JP Morgan analysts see AstraZeneca PLC (LSE:AZN) in a strong position to dominate the market for a new breast cancer treatment if upcoming clinical trial results are positive. Its drug candidate, camizestrant, or "cami", is undergoing testing in a pivotal phase III trial, named SERENA-6, aimed at treating advanced breast cancer.
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
Monopar Therapeutics Inc. MNPR stock is skyrocketing on Thursday.
AstraZeneca Receives CHMP's Approval for Wainzua in Europe
The CHMP recommends approval for AZN's Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.
AZN or NVO: Which Is the Better Value Stock Right Now?
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Astrazeneca (AZN) and Novo Nordisk (NVO). But which of these two stocks offers value investors a better bang for their buck right now?
Astrazeneca (AZN) Loses -5.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Astrazeneca (AZN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
UK bosses get green light to hike pay from investment body
Britain's bosses have been given the green light to pay themselves more by their institutional owners Institutional trade body the Investment Association made the call in a new set of guidelines issued today designed to halt a brain drain of top management talent to better-paid jobs in the US. After years of its members hectoring bosses over pay, the IA now says it will introduce principles to enable them to vote through large awards without breaching any guidelines.
